Comparing two different doses of Atorvastatin for decrease the level of LDL in ACS patient.

Phase 3

• Conditions: acute coronary syndrome.; Acute ischemic heart disease, unspecified; I24.9

• Registration Number: IRCT20140921019240N4
• Lead Sponsor: Sabzevar University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 January 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

?ACS (acute coronary syndrom) patients who are admit in CCU (coronary care unit) in Heshmatie hospital

Exclusion Criteria

The normal coronary patients
The patients who are more than 75 years old
The patients who are using Fibrate drugs in the same time
The patients who are living in the villages and disable for follow up

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ow density lipoprotein. Timepoint: At the start of study & 3 months later. Method of measurement: Blood test.;MDR1 (Multi-Drug Resistance ) gene polymorphism. Timepoint: At the start of study. Method of measurement: Polymerase Chain Reaction.